Wednesday, July 8, 2026

pharma · Atopic Dermatitis · Alopecia Areata

Forteo

Forteo is a pharma organization headquartered in Las Vegas, USA. Primary therapeutic focus areas include Atopic Dermatitis, Alopecia Areata, Celiac Disease, Vitiligo, Osteoarthritis, Knee. NovaPharmaNews links 5 clinical

Las Vegas, USA HQ
20 Employees
PMDA registrant Type
Company details
Status
Public
HQ
Las Vegas, USA
Employees
20
Programs
5
Drugs
0
Patents
3
Clinical program

Signature Cord Prime

Phase 1 · mab · Osteoarthritis, Knee

Signature Cord Prime for Osteoarthritis, Knee is a Phase 1 program (mab) at Forteo with 1 ClinicalTrials.gov record(s).

← All Forteo projects Phase 1 mab active

Internal code SIG001-OAK-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Forteo
Phase
Phase 1
Modality
mab
Indication
Osteoarthritis, Knee
Status
active
Trials
1

Clinical trials